The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Renal Insufficiency, Chronic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Renal Insufficiency, Chronic


Psychiatry related information on Renal Insufficiency, Chronic


High impact information on Renal Insufficiency, Chronic


Chemical compound and disease context of Renal Insufficiency, Chronic


Biological context of Renal Insufficiency, Chronic


Anatomical context of Renal Insufficiency, Chronic


Gene context of Renal Insufficiency, Chronic


Analytical, diagnostic and therapeutic context of Renal Insufficiency, Chronic


  1. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F., Motolese, M., Ponticelli, C., Ritz, E., Zucchelli, P. N. Engl. J. Med. (1996) [Pubmed]
  2. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. Slatopolsky, E., Weerts, C., Thielan, J., Horst, R., Harter, H., Martin, K.J. J. Clin. Invest. (1984) [Pubmed]
  3. Acute toxic effects of sustained-release verapamil in chronic renal failure. Pritza, D.R., Bierman, M.H., Hammeke, M.D. Arch. Intern. Med. (1991) [Pubmed]
  4. Therapeutic use of growth factors in renal failure. Hammerman, M.R., Miller, S.B. J. Am. Soc. Nephrol. (1994) [Pubmed]
  5. Heparin-induced hyperkalemia. Edes, T.E., Sunderrajan, E.V. Arch. Intern. Med. (1985) [Pubmed]
  6. Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis. Kim-Sing, A., Kays, M.B., James, V.E., Weart, C.W. The Annals of pharmacotherapy. (1993) [Pubmed]
  7. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., Zidek, W. N. Engl. J. Med. (2000) [Pubmed]
  8. Effect of benazepril in chronic renal insufficiency. Apperloo, A.J., Rensma, P.L. N. Engl. J. Med. (1996) [Pubmed]
  9. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. Solomon, R., Werner, C., Mann, D., D'Elia, J., Silva, P. N. Engl. J. Med. (1994) [Pubmed]
  10. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. Rao, D.S., Shih, M.S., Mohini, R. N. Engl. J. Med. (1993) [Pubmed]
  11. Letter: Calcifediol in chronic renal insufficiency. Coburn, J.W., Norman, A.W. JAMA (1976) [Pubmed]
  12. Renal and electrolyte disturbances associated with cisplatin. Blachley, J.D., Hill, J.B. Ann. Intern. Med. (1981) [Pubmed]
  13. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency. Wolfe, M.W., Saad, R.M. Arch. Intern. Med. (1989) [Pubmed]
  14. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. Tonelli, M., Moyé, L., Sacks, F.M., Cole, T., Curhan, G.C. J. Am. Soc. Nephrol. (2003) [Pubmed]
  15. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3. Voigts, A.L., Felsenfeld, A.J., Llach, F. Arch. Intern. Med. (1983) [Pubmed]
  16. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency. Mathias, R.S., Nguyen, H.T., Zhang, M.Y., Portale, A.A. J. Am. Soc. Nephrol. (1998) [Pubmed]
  17. Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Barbanoj, M., Antonijoan, R., Morte, A., Grinyó, J.M., Solà, R., Vallès, J., Peraire, C., Cordero, J.A., Muñoz, A., Jané, F., Obach, R. Clin. Pharmacol. Ther. (1999) [Pubmed]
  18. Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils. Jaisson, S., Lorimier, S., Ricard-Blum, S., Sockalingum, G.D., Delevallée-Forte, C., Kegelaer, G., Manfait, M., Garnotel, R., Gillery, P. Chem. Biol. (2006) [Pubmed]
  19. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Nagano, N. Pharmacol. Ther. (2006) [Pubmed]
  20. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency. Mitchell, H.C., Smith, R.D., Cutler, R.E., Sica, D., Videen, J., Thompsen-Bell, S., Jones, K., Bradley-Guidry, C., Toto, R.D. Am. J. Kidney Dis. (1997) [Pubmed]
  21. Increased histidine and histamine content in the brain of chronic uremic rats. Cause of enhanced cerebral cyclic adenosine monophosphate in uremia? Schmid, G., Przuntek, H., Fricke, L., Heidland, A., Hempel, K. Am. J. Clin. Nutr. (1978) [Pubmed]
  22. Lithium stimulates the release of human parathyroid hormone in vitro. Birnbaum, J., Klandorf, H., Giuliano, A., Van Herle, A. J. Clin. Endocrinol. Metab. (1988) [Pubmed]
  23. Haematological toxicities associated with dose-intensive chemotherapy, the role for and use of recombinant growth factors. Henry, D. Ann. Oncol. (1997) [Pubmed]
  24. Sodium potassium ATPase activity in human rectal mucosa with and without renal insufficiency. Hené, R.J., Boer, P., Koomans, H.A., Dorhout Mees, E.J. Am. J. Kidney Dis. (1985) [Pubmed]
  25. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP mRNA expression of adult rat cardiac myocytes. Yu, J.Z., Bondy, G.P., Allard, M.F., Thompson, C.R., Levin, A., McManus, B.M. J. Mol. Cell. Cardiol. (1996) [Pubmed]
  26. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Meier, J.J., Nauck, M.A., Kranz, D., Holst, J.J., Deacon, C.F., Gaeckler, D., Schmidt, W.E., Gallwitz, B. Diabetes (2004) [Pubmed]
  27. Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy. Van Wyck, D.B. Nephrol. Dial. Transplant. (2000) [Pubmed]
  28. Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy. Frieling, J.T., van Hamersvelt, H.W., Wijdenes, J., Hendriks, T., Sauerwein, R.W., van Der Linden, C.J. American journal of nephrology. (1999) [Pubmed]
  29. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Blydt-Hansen, T.D., Tenenhouse, H.S., Goodyer, P. Pediatr. Nephrol. (1999) [Pubmed]
  30. Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remnant kidney model. Hugo, C., Kang, D.H., Johnson, R.J. Nephron (2002) [Pubmed]
  31. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency. Meyer, T.W., Anderson, S., Rennke, H.G., Brenner, B.M. Am. J. Med. (1985) [Pubmed]
  32. Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Anto, H.R., Chou, S.Y., Porush, J.G., Shapiro, W.B. Arch. Intern. Med. (1981) [Pubmed]
  33. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Saito, K., Fujigaki, S., Heyes, M.P., Shibata, K., Takemura, M., Fujii, H., Wada, H., Noma, A., Seishima, M. Am. J. Physiol. Renal Physiol. (2000) [Pubmed]
WikiGenes - Universities